Mechanisms that regulate endothelial nitric oxide synthase (eNOS) expression in normal and hypoxic pulmonary circulation are poorly understood. Lung eNOS expression is increased after chronic hypoxic pulmonary hypertension in rats, but whether this increase is due to altered hemodynamics or to hypoxia is unknown. Therefore, to determine the effect of blood flow changes on eNOS expression in the normal pulmonary circulation, and to determine whether the increase in eNOS expression after chronic hypoxia is caused by hemodynamic changes or low oxygen tension, we compared eNOS expression in the left and right lungs of normoxic and chronically hypoxic rats with surgical stenosis of the left pulmonary artery (LPA). LPA stenosis in normoxic rats reduced blood flow to the left lung from 9.8+/-0.9 to 0.8+/-0.4 ml/100 mg/min (sham surgery controls vs. LPA stenosis, P < 0.05), but there was not a significant increase in right lung blood flow. When compared with the right lung, eNOS protein and mRNA content in the left lung was decreased by 32+/-7 and 54+/-13%, respectively (P < 0.05), and right lung eNOS protein content was unchanged. After 3 wk of hypoxia, LPA stenosis reduced blood flow to the left lung from 5.8+/-0.6 to 1.5+/-0.4 ml/100 mg/min, and increased blood flow to the right lung from 5.8+/-0.5 to 10.0+/-1.4 ml/ 100 mg/min (sham surgery controls vs. LPA stenosis, […] Research Article
Introduction
The endothelium contributes to local regulation of vascular smooth muscle tone by releasing various vasoactive products, including nitric oxide (NO). 1 The enzyme responsible for NO production in the endothelium of the vascular wall is type III endothelial NO synthase (eNOS; 1). NO is produced by a reaction using the amino acid L -arginine and molecular oxygen as substrates, and other cofactors including NADPH, tretrahydrobiopterin, FAD, and FMN. NO, or a closely related molecule, stimulates vascular smooth muscle relaxation through activation of soluble guanylate cyclase to produce cGMP (2) . Although constitutively expressed by endothelial cells, eNOS gene expression is regulated by various stimuli, including shear stress and hypoxia (3) .
In normal adult rats, NO does not appear to play a major role in the maintenance of low basal pulmonary vascular tone (4) . After exposure to chronic hypoxia, however, eNOS expression is induced in small resistance vessels (5) , and inhibition of NO synthesis causes marked vasoconstriction (6) . NO plays a more active role in regulating basal pulmonary vascular tone in humans, as reflected by the increase in pulmonary vascular resistance with NO synthase inhibition (7) . In addition to its direct effect on vascular tone, NO may play other roles in the vasculature, including regulating vascular smooth muscle cell proliferation (2) .
Inhaled NO acutely reduces high vascular tone in experimental and clinical pulmonary hypertension (8) . Chronic inhalation of NO reduces hypertensive structural remodeling of small pulmonary arteries in hypoxic rats (9) . Although it has been hypothesized that eNOS expression and NO production might be decreased in pulmonary hypertension, several studies have found that NO production and eNOS expression is increased in rats after chronic hypoxic pulmonary hypertension (10, 11, 5) . The mechanism for eNOS upregulation with chronic hypoxia is unknown. It is possible that altered hemo-dynamic stimuli, such as increased pressure or shear stress, or decreased oxygen tension upregulates eNOS expression.
The eNOS gene contains a shear stress response element, and eNOS expression is increased by shear stress in vitro (12) . However, in vivo data concerning regulation of eNOS expression is less clear. Chronic exercise increases eNOS expression in the endothelium of adult dogs, but whether this expression is due to increased flow, shear stress, or to other effects of exercise was not determined (13) . Increases in blood flow in the systemic circulation caused by an arteriovenous shunt also increased aortic eNOS expression (14) . Recently we have shown that chronic increases in pulmonary artery pressure decrease eNOS expression in the ovine fetal lung (15) . Thus, lung eNOS expression may be modified by alterations in hemodynamic forces independently of the effects of hypoxia.
To examine the relative roles of hemodynamic forces and chronic hypoxia in eNOS expression in the pulmonary circulation, we performed a series of experiments using rats with altered left pulmonary artery blood flow. Surgical banding of the left pulmonary artery (LPA) was performed on adult male rats, reducing blood flow to the left lung. The use of rats with LPA stenosis allowed us to study the effect of decreased pulmonary blood flow on lung eNOS expression. Since LPA banding protects the left lung from hypertensive changes induced by chronic hypoxia (16), we used this model to help differentiate the direct effects of chronic hypoxia from hemodynamic forces on lung eNOS expression.
Methods

Animals
All procedures and experiments were approved by the University of Colorado and the University of Virginia Health Sciences Center Animal Care Committees. LPA banding surgery was performed on Sprague Dawley adult male rats (250-300 g) at Zivic-Miller Laboratories (Portersville, PA). Stenosis was produced by tying a 3-0 silk suture around a blunt needle and the LPA, and then removing the needle. The gauge of the needle was used to determine the approximate diameter of the silk band, and to ensure uniformity in the degree of stenosis. 25-gauge needles were used for LPA banding (16). Sham surgery was performed on age-matched male rats to control for any effects of surgery itself. Surgery in the sham surgery control animals was performed in the same manner as for the LPA stenosis rats, but the ligature was removed before closing around the LPA. Rats were shipped 2 d after surgery.
Normoxic protocol
Normoxia groups (LPA stenosis rats and sham surgery controls) were kept in room air for 4 wk with a 12-h light/12-h dark cycle, and were allowed free access to rat chow and water.
Hypoxic protocol
Chronic hypoxia groups (LPA stenosis rats and sham surgery controls) were placed in a hypobaric chamber and exposed to progressive increases in simulated altitude over 1 wk until they reached 17,000 ft. (FiO 2 ϭ 0.10), and were then kept at that altitude for 3 wk. The chamber was ventilated continuously with room air to prevent accumulation of carbon dioxide, ammonia, and water vapor, as previously described (6) . The chronically hypoxic rats were exposed to 12-h light/12-h dark cycles, and were allowed free access to rat chow and water in the hypobaric chamber. Hypoxic rats were exposed to FiO 2 ϭ 0.10 for 24 h a day, except for brief periods ( Ͻ 10 min) when chambers were returned to atmospheric pressure for cage cleaning and replenishing of food and water.
At the end of the study period, rats were anesthetized with ketamine (100 mg/kg; Fort Dodge Labs, Fort Dodge, IA) and xylazine (12 mg/kg; Miles, Shawnee, KS) and a thoracotomy was performed. A catheter was inserted into the main pulmonary artery (MPA), and the lungs were perfused with heparinized saline (1 U/ml), until the effluent was clear of blood. After perfusion the lungs were either ( a ) removed and snap-frozen in liquid nitrogen, stored at Ϫ 70 Њ C, and subsequently used for extraction of RNA and protein for Northern and Western blot analysis; or ( b ) perfused with paraformaldehyde through the MPA, and then molten agarose-injected through the trachea to inflate the airways, and then placed in formalin for paraffin embedding. Paraffin-embedded tissue was used for histology and eNOS immunolocalization.
Chronically hypoxic rats used for hemodynamic studies were removed from the high altitude chamber after 20 d at 17,000 ft. for surgery and instrumentation, and were then returned to the chamber for the remaining time period.
Hemodynamic studies
Surgery and instrumentation. Hemodynamic measurements were performed as previously described (17) . Catheters were placed in the right carotid artery, MPA, and jugular vein. Rats were either housed in room air or returned to the high altitude hypoxia chamber (FiO 2 ϭ 0.10) for the remainder of the time period. Upon removal from normoxia or hypoxia, conscious rats were placed in a ventilated clear plastic chamber during hemodynamic measurements and pulmonary and systemic blood pressure determinations. Heart rates were measured, and mean pressures were calculated. Cardiac outputs (CO) were measured by the standard dye-dilution technique. Hemodynamic measurements were performed while all the rats were breathing room air, and also subsequently in the hypoxic groups while breathing hypoxic gas (FiO 2 ϭ 0.10).
Measurement of lung blood flow using radiolabeled microspheres. Radiolabeled microspheres were used to measure lung and kidney blood flows as previously described (18) . 46 Sc-labeled 15-m microspheres were injected into the right jugular vein for measurement of blood flows while the rats were exposed to room air. The hypoxic rat groups were then exposed to hypoxic gas for 5 min, at which time hemodynamic measurements were again taken and 113 Sn-labeled 15-m microspheres were injected. The heart was removed for measurement of right ventricular hypertrophy (RVH). Left and right lungs and left and right kidneys were collected for counting of radioisotope content. Kidney flow was measured to determine systemic escape of any microspheres. Organ flows in ml/min were calculated as [(cardiac output) ϫ (organ cpm)]/(total injected cpm).
Northern blot analysis
Northern blot analysis was performed according to previously published methods (5, 19) , with 20 g of total RNA per rat lung and a rat cDNA probe for eNOS (a kind gift from Dr. Hideki Takahashi, Dept. of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan). 18S rRNA levels were measured by hybridization with an oligonucleotide probe (ACGGTATCTGATCCGTCTTC-GAACC) labeled with 32 P-dCTP using terminal deoxytransferase (Boehringer Mannheim Biochemicals, Indianapolis, IN). Densitometry was performed using a scanner and National Institutes of Health Image software (Bethesda, MD).
Western blot analysis
Western blot analysis was performed using 25 g of lung protein according to a previously published method (5) with a monoclonal antibody to eNOS (Transduction Laboratories, Lexington, KY). Densitometry was performed with a scanner and National Institutes of Health Image software. Western blot analysis with increasing amounts of lung protein from a hypoxic sham control rat showed that there was a linear increase in eNOS protein signal, and that the amount of protein (25 g) used for comparison of control and treatment groups fell within the linear range of the Western blot analysis.
Histology and immunohistochemical staining for eNOS protein
Small pieces of lung (2-6 mm) were placed in 10% buffered formalin and paraffin-embedded. Paraffin sections 5 m thick were serially mounted onto Superfrost Plus™ slides (Fisher Scientific Co., Fairlawn, NJ). Hemotoxylin and eosin staining was performed on left and right lungs from three animals in each study group. At least three sections per lung, and left and right lungs for each animal were assessed for histologic changes. For eNOS immunostaining, slides were dewaxed in 100% xylene. Sections were rehydrated by immersion in 100% ethanol; 95% ethanol/5% water; 70% ethanol/30% water; and then 100% water. Antigen retrieval was performed by boiling the slides in 0.01 M citric acid, pH 6.0. Slides were washed in PBS (2.7 mM KCl, 1.2 mM KH 2 PO 4 , 138 mM NaCl, 8.1 mM Na 2 HPO 4 ϭ 1 ϫ PBS). Endogenous biotin in the tissue sections was blocked by glucose, glucose oxidase treatment (0.2 M glucose, 1.5 U/ml glucose oxidase [Boehringer Mannheim Biochemicals] in 1 ϫ PBS). The slides were washed in 1 ϫ PBS. Sections were blocked with Super Block™ (Sky Tek, Logan, Utah) diluted 1:10 (vol/vol) in 1 ϫ PBS, and were then incubated with anti-eNOS monoclonal antibody (Transduction Laboratories) diluted 1:10,000, or an IgG 1 negative control (Jackson Laboratories, West Grove, PA) diluted 1:10,000 in 1 ϫ PBS, 2% (wt/vol) BSA, 0.1% (wt/vol) NaN 3 . After incubation with the primary antibodies, sections were washed in 1 ϫ PBS. Biotin-labeled anti-mouse secondary antibody (Vector Laboratories, Inc., Burlingame, CA) was incubated with the sections at a dilution of 1:200 in 1 ϫ PBS, 2% (wt/ vol) BSA, 0.1% (wt/vol) NaN 3 . Again, the slides were washed in 1 ϫ PBS. Slides were incubated in streptavidin-biotin-horseradish peroxide solution and developed with diaminobenzidine (DAB) and hydrogen peroxide, with nickel chloride for enhancement (Vector). The NiCl enhancement-DAB color development reaction was stopped by washing with water, and then the slides were dehydrated in 70% ethanol/30% water, 95% ethanol/5% water; 100% ethanol, and finally 100% xylene before coverslipping.
Data analysis
All data is expressed as mean Ϯ SEM. Unpaired t tests were performed on the quantitative data to test for statistical differences between the groups. Data groups were considered as significantly different if P Ͻ 0.05. Each group contained at least four rats.
Results
All study groups showed a gain in total body weight of 98-122 g (Table I) , and there were no differences among the groups. Hemodynamic measurements were made while the four groups were breathing room air (Table II) , and also with the hypoxic rats exposed to FiO 2 ϭ 0.10. COs were not different among the groups.
Normoxic groups
Organ weights and hemodynamics. In comparison with sham surgery control animals, LPA stenosis reduced left lung weight by 26%, but did not significantly alter right lung weight (Table  I ). The ratio of the left/right lung weight was reduced in the LPA stenosis rats. Right ventricle/left ventricle + septum weights were similar in sham and LPA stenosis groups. In normoxic rats, LPA stenosis reduced blood flow to the left lung, and there was no significant change in right lung blood flow compared with sham surgery controls (Table II) . When calculated as percentage flow, LPA stenosis reduced blood flow to the left lung from 52 Ϯ 5% to 7 Ϯ 3% (sham surgery controls vs. LPA stenosis). Main pulmonary artery pressure (PAP) was increased by LPA stenosis compared with the sham surgery con- trols, but total pulmonary vascular resistance (TPR) was not different.
Histology. Muscularized pulmonary arteries in the right and left lungs of the LPA stenosis group under normoxia showed normal vascular structure, as also shown by the sham surgery controls (Fig. 1) .
eNOS mRNA, protein levels, and localization. In normoxic rats, LPA stenosis decreased eNOS mRNA levels in the left lung by 54Ϯ13% (P Ͻ 0.05) compared with the right lung (Fig.  2) . In normoxic rats, LPA stenosis decreased eNOS content in the left lung by 32Ϯ7% (P Ͻ 0.05) compared with sham surgery controls (Fig. 3) . Immunohistochemical staining localized eNOS protein to large and medium vessels in normoxic rat lungs. In the LPA stenosis rats, a similar pattern of staining was seen in both left and right lungs (Fig. 4) .
Hypoxic groups
Organ weights and hemodynamics. In rats exposed to chronic hypoxia, LPA stenosis increased right lung weight and decreased left lung weight, resulting in a lower left/right lung weight ratio (Table I) . Although RVH increased with hypoxia, there was not a further increase after LPA stenosis (Table II) . PAP and TPR increased in both hypoxic groups compared with normoxic groups. In hypoxic rats, LPA stenosis reduced blood flow to the left lung and increased blood flow to the right lung. When calculated as percentage blood flows, LPA stenosis reduced blood flow to the left lung from 50Ϯ5 to 13Ϯ3% (sham surgery controls vs. LPA stenosis, respectively; P Ͻ 0.05), and increased right lung blood flow from 50Ϯ4 to 87Ϯ12% (sham surgery controls vs. LPA stenosis, respectively; P Ͻ 0.05). Left and right lung blood flows in the chronically hypoxic LPA stenosis rats were not different from blood flows in the normoxic LPA stenosis rats. The hypoxic LPA stenosis rats had higher PAP compared with the hypoxic sham surgery controls, but TPR was not different (Table II) . When the hypoxic groups were exposed to FiO 2 ϭ 0.10 and hemodynamic measurements were repeated, there was a significant increase in PAP in the LPA stenosis group (43Ϯ2 to 54Ϯ3 mmHg). Blood flows, CO, and TPR were not different from measurements made while the rats were breathing room air.
Histology. With exposure to chronic hypoxia, the right lungs of the LPA stenosis rats showed thickening of the muscular medial layer, and were similar in structure to the lungs of the chronically hypoxic sham surgery controls (Fig. 1) . After LPA stenosis, the left lungs did not develop the hypertensive changes seen in the right lungs and the hypoxic sham surgery controls (Fig. 1) . Histology of the left lung of the LPA stenosis group was similar to that of the normoxic animals.
eNOS mRNA, protein levels, and localization. In hypoxic rats, there was no difference in eNOS mRNA levels between left and right lungs with LPA stenosis (Fig. 2) . After 3 wk of hypoxia, lung eNOS protein content increased 1.5-fold in sham surgery controls compared with normoxic controls (Fig. 5) . Lung eNOS protein expression also increased in both left and right lungs of the hypoxic LPA stenosis rats (Fig. 6) , and was not different from eNOS protein levels in the hypoxic sham surgery controls (Fig. 7) . There was no difference between left and right lung eNOS protein content in either the hypoxic LPA stenosis rats or hypoxic sham surgery controls (Fig. 7) . Chronically hypoxic rats showed staining for eNOS in small vessels as well as medium and large vessels (Fig. 4) . The pattern of eNOS staining was similar in left and right lungs of both LPA stenosis rats and sham surgery control lungs. There were no differences in the distribution of eNOS staining between LPA stenosis rats and sham surgery controls. Staining for eNOS was also detected in the bronchial epithelium, particularly on the apical surface of the epithelial cells. No differences in bronchial staining for eNOS could be seen between the different treatment groups.
Discussion
We found that reduction of pulmonary blood flow due to LPA stenosis decreased eNOS mRNA and protein expression in the normoxic adult rat lung. Although blood flow was decreased by 8.6-fold in the left lung of normoxic LPA stenosis rats, there was a 32% decrease in eNOS protein and a 54% decrease in eNOS mRNA expression. Blood flow to the right lung did not change with LPA stenosis, and there was no change in eNOS expression. Exposure of LPA stenosis rats to chronic hypoxia increased eNOS gene expression in both left and right lungs despite marked reduction of blood flow to the left lung (4.0-fold) and increased flow to the right lung (1.7-fold). After chronic hypoxia, there was no difference in eNOS mRNA and protein content between left and right lungs. Hence, chronic hypoxia increased lung eNOS gene expression despite altered hemodynamics as assessed by direct measurements of reduced blood flow and by histologic evidence of reduced hypertensive remodeling in the left lung. These findings suggest that (a) normal pulmonary blood flow maintains eNOS mRNA and protein content in the normoxic rat lung, and (b) that chronic hypoxia increases lung eNOS gene expression primarily because of hypoxia or hypoxia-induced factors rather than hypertension or other hemodynamic factors.
In vitro studies have shown that increased shear stress upregulates eNOS expression (12) , implying that this mechanism may also be operative in vivo. In in vivo studies of the systemic circulation where shear stress may have been increased, such as in chronically exercised dogs, eNOS expression was increased in the aortic endothelium (13) . In a rat model of high blood flow created by an arteriovenous shunt, eNOS mRNA and protein were also found to be increased in the aorta (14) . Our study showed that in the chronically hypoxic pulmonary circulation, increases in blood flow or pressure had no effect on eNOS expression. Although decreased pulmonary blood flow reduced eNOS expression in normoxic rats, it is possible that this decrease in eNOS expression may also be influenced by other mechanisms such as altered growth factor activity, which may be associated with reduction in the size of the left lungs after LPA stenosis. In a recent paper, Resta et al. (20) reported that eNOS expression was increased in the arteries, but not in the veins of chronically hypoxic rat lungs. They suggested that hypertension or increased shear stress may be responsible for selective upregulation of pulmonary arterial eNOS, but could not preclude a role for hypoxia.
The model used in this study was originally described by Rabinovitch et al. (16). They reported that banding the left pulmonary artery decreased blood flow and pressure in the left lung of chronically hypoxic rats. This decrease prevented both muscular extension into previously nonmuscular peripheral pulmonary arteries and medial hypertrophy of normally muscular arteries. Histologic and hemodynamic results in our study were comparable to those reported by Rabinovitch et al. (16), and confirmed that LPA banding prevents the hypertensive changes usually associated with chronic hypoxia. Therefore, despite altered blood pressure and flow in the left lung of the hypoxic LPA stenosis rats, chronic hypoxia increased eNOS expression to a similar degree in left and right lungs. Potential limitations of this study include lack of bronchial blood flow measurements. Results reported are for a single time point. Because of the small size of the banded left pulmonary artery, we were not able to measure pressure distal to the band. Potential effects of changes in the bronchial circulation on lung eNOS expression are unknown. Hemodynamic effects on lung eNOS expression at earlier and later time points were not examined in this study, but will be the subject of future studies. Staining for eNOS was also detected in the bronchial epithelium, particularly on the apical surface of the epithelial cells. No differences in bronchial staining for eNOS could be seen among the different treatment groups. The contribution that bronchial eNOS protein makes towards whole-lung eNOS protein levels is not known. In conclusion, this study suggests that hemodynamics contribute to the regulation of eNOS expression in the normal pulmonary circulation as evidenced by the fall in lung eNOS expression after reduction of pulmonary blood flow in normoxia. With chronic hypoxia, eNOS expression was increased to similar levels in left and right lungs with LPA stenosis despite large differences in blood flows and presumably pressures. We suggest that the increase in eNOS expression after chronic hypoxic pulmonary hypertension may be due to the direct effects of hypoxia or hypoxia-induced factors independently of changes in hemodynamics.
